Choose a language and wait for the translated text.
The San Diego, California -based โcompany is aiming to raise up to $371.9 million in the IPO by offering 21.9 million shares priced between $15 and $17 each.
ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO | PharmaVoice
